3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Phase 2
1
Status
Recruiting
97
Active not recruiting
57
Completed
22
Not yet recruiting
16
Terminated
10
Withdrawn
3
Enrolling by invitation
3
Suspended
2
Available
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Neoplasms
12
Prostatic Neoplasms
8
Recurrence
4
Lung Neoplasms
4
Breast Neoplasms
4
Urinary Bladder Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Lymphoma, B-Cell
3
Lymphoma
3
Colorectal Neoplasms
3
Cancer Pain
3
Uterine Cervical Neoplasms
2
Urologic Neoplasms
2
Triple Negative Breast Neoplasms
2
Solid Tumor
2
Small Cell Lung Carcinoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Ovarian Neoplasms
2
Non-Muscle Invasive Bladder Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Head and Neck Neoplasms
2
Glioblastoma
2
Cholangiocarcinoma
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Withdrawn
×
Urinary Bladder Neoplasms
×
90 days
×
Clear all
NCT05714826
2026-05-27
COARC
University of Texas Southwestern Medical Center
Phase NA
Withdrawn
NCT02143804
2026-04-02
exBOND
CG Oncology, Inc.
Phase 2
Withdrawn
NCT07313891
2026-03-17
BOOST
Relmada Therapeutics, Inc.
Phase 3
Withdrawn